0001512848-20-000003.txt : 20200205 0001512848-20-000003.hdr.sgml : 20200205 20200205153447 ACCESSION NUMBER: 0001512848-20-000003 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 EFFECTIVENESS DATE: 20200205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCH VENTURE CORP CENTRAL INDEX KEY: 0001274403 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19358 FILM NUMBER: 20578556 BUSINESS ADDRESS: STREET 1: C/O ARCH VENTURE PARTNERS STREET 2: 8755 W. HIGGINS RD. #1025 CITY: CHICAGO STATE: IL ZIP: 60631 BUSINESS PHONE: 7733806600 MAIL ADDRESS: STREET 1: C/O ARCH VENTURE PARTNERS STREET 2: 8755 W. HIGGINS RD. #1025 CITY: CHICAGO STATE: IL ZIP: 60631 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001274403 XXXXXXXX 12-31-2019 12-31-2019 ARCH VENTURE CORP
C/O ARCH VENTURE PARTNERS 8755 W. HIGGINS RD. #1025 CHICAGO IL 60631
13F HOLDINGS REPORT 028-19358 N
Mark McDonnell Managing Director, CFO and CAO 773-380-6600 /s/ Mark McDonnell Chicago IL 02-05-2020 0 5 76733 false
INFORMATION TABLE 2 ARCH.xml ADESTO TECHNOLOGIES CORP. COM 00687D101 17438 2051511 SH SOLE 0 0 2051511 CHIASMA INC COM 16706W102 5936 1196776 SH SOLE 0 0 1196776 KURA ONCOLOGY INC COM 50127T109 5587 406307 SH SOLE 0 0 406307 RUBIUS THERAPEUTICS INC COM 78116T103 24874 2618351 SH SOLE 0 0 2618351 SYROS PHARMACEUTICALS INC COM 87184Q107 22898 3313817 SH SOLE 0 0 3313817